According to Codexis 's latest financial reports the company's current revenue (TTM) is $70.14 M. In 2022 the company made a revenue of $0.13 B an increase over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $70.14 M | -49.39% |
2022 | $0.13 B | 32.3% |
2021 | $0.10 B | 51.7% |
2020 | $69.05 M | 0.87% |
2019 | $68.45 M | 12.98% |
2018 | $60.59 M | 21.13% |
2017 | $50.02 M | 2.43% |
2016 | $48.83 M | 16.83% |
2015 | $41.8 M | 18.4% |
2014 | $35.3 M | 10.6% |
2013 | $31.92 M | -63.85% |
2012 | $88.29 M | -28.71% |
2011 | $0.12 B | 15.65% |
2010 | $0.10 B | 29.18% |
2009 | $82.9 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 83,296.78% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 85,602.07% | ๐บ๐ธ USA |
Dupont De Nemours DD | $12.06 B | 17,104.85% | ๐บ๐ธ USA |
Balchem BCPC | $0.92 B | 1,215.08% | ๐บ๐ธ USA |